Back to Search
Start Over
The density of mast cells c-Kit + and tryptase + correlates with each other and with angiogenesis in pancreatic cancer patients.
- Source :
-
Oncotarget [Oncotarget] 2017 Jul 31; Vol. 8 (41), pp. 70463-70471. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- Literature data suggest that inflammatory cells such as mast cells (MCs) are involved in angiogenesis. MCs can stimulate angiogenesis by releasing of well identified pro-angiogenic cytokines stored in their cytoplasm. In particular, MCs can release tryptase, a potent in vivo and in vitro pro-angiogenic factor. Nevertheless, few data are available concerning the role of MCs positive to tryptase in primary pancreatic cancer angiogenesis. This study analyzed the correlation between mast cells positive to c-Kit receptor (c-Kit <superscript>+</superscript> MCs), the density of MCs expressing tryptase (MCD-T) and microvascular density (MVD) in primary tumor tissue from patients affected by pancreatic ductal adenocarcinoma (PDAC). A series of 35 PDAC patients with stage T <subscript>2-3</subscript> N <subscript>0-1</subscript> M <subscript>0</subscript> (by AJCC for Pancreas Cancer Staging 7 <superscript>th</superscript> Edition) were selected and then undergone to surgery. Tumor tissue samples were evaluated by mean of immunohistochemistry and image analysis methods in terms of number of c-Kit <superscript>+</superscript> MCs, MCD-T and MVD. The above parameters were related each other and with the most important main clinico-pathological features. A significant correlation between c-Kit <superscript>+</superscript> MCs, MCD-T and MVD groups each other was found by Pearson t-test analysis (r ranged from 0.75 to 0.87; p-value ranged from 0.01 to 0.04). No other significant correlation was found. Our in vivo preliminary data, suggest that tumor microenvironmental MCs evaluated in terms of c-Kit <superscript>+</superscript> MCs and MCD-T may play a role in PDAC angiogenesis and they could be further evaluated as a novel tumor biomarker and as a target of anti-angiogenic therapy.<br />Competing Interests: CONFLICTS OF INTEREST The authors declare that there is no conflicts of interest.
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 8
- Issue :
- 41
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Academic Journal
- Accession number :
- 29050294
- Full Text :
- https://doi.org/10.18632/oncotarget.19716